Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 3330
Journal of Biotechnology & Biomaterials received 3330 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Access to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Activity of derived extracts from Annona coriacea Mart. on head and neck tumor lines
2nd World Biotechnology Congress
Aline T M Coelho, Rodolfo E M Ribeiro, Ana G Silva, Gilvania A R Cordeiro, Joao G M Junqueira, Vanessa G P Severino, Renato J S Oliveira, Rui M V Reis and Rosy I M A Ribeiro
UFSJ, Brazil UFG, Brazil HCB-CPOM, Brazil
ScientificTracks Abstracts: J Biotechnol Biomater
Abstract
Head and neck squamous cell carcinoma (HNSCC) makes up about 90% of head and neck neoplasms. The treatment is aggressive, the 5-year survival rate is around 50-60% and the local recurrence is 20-30%. Studies report that the use of new antitumor drugs of natural origin, besides efficient, offers a wide field for new research. So the objective of this work is to identify the antineoplastic potential of seven extracts of the species Annona coriacea Mart. on head and neck tumor lines. In the cell viability assay, only the compound C4 did not reach representative IC50 values on the tested lines (HN13 and FaDu). Of the seven compounds, four (C1, C2, C3, and C5) exhibited better results and were selected to follow in further assays. In the cell migration assay, it was seen that the C2, C3, and C5 compounds inhibited the migration in HN13 and C3 and C5 in FaDu, above all in 48 hours after treatment. Changes in cell morphology were observed in the lines, which after treated with the compounds in the time of 48 hours showed cytoplasmic projections and vacuoles (HN13) and higher nuclear condensation (FaDu) compared to the control (Images 3 and 4). The results of this study contribute to the development of new antineoplastics that may help the treatment of HNSCC improving the prognosis and leading to cure.Biography
Aline T M Coelho is a Biochemistry student at Federal University of São João del-Rei, Campus Centro-Oeste Dona Lindu (UFSJ-CCO), Technician in Pharmacy by the institution Conceição Ferreira Nunes, Divinópolis/Mg and student of scientific initiation in the Laboratory of Experimental Pathology (Lapatex), UFSJ-CCO.
